Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001086002 | SCV000289955 | benign | Spastic paraplegia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000386665 | SCV000345522 | likely benign | not specified | 2016-09-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000761852 | SCV000892057 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | SACS: BP4, BP7, BS2 |
Athena Diagnostics | RCV000761852 | SCV001145328 | benign | not provided | 2018-12-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001109613 | SCV001266967 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001109613 | SCV001653327 | likely benign | Charlevoix-Saguenay spastic ataxia | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000761852 | SCV001891056 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847974 | SCV002105025 | likely benign | Hereditary spastic paraplegia | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001109613 | SCV002086703 | likely benign | Charlevoix-Saguenay spastic ataxia | 2020-09-25 | no assertion criteria provided | clinical testing |